StockData
Disc Medicine, Inc. logo

Disc Medicine, Inc. (IRON) stock

IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$76.57−0.02 (-0.03%)

Close on Nov 17, 2026Market cap $2.94BP/E –Yield –

Disc Medicine total assets

Total assets on the balance sheet at the end of each period.

Disc Medicine's total assets was $735.07M at Jun 30, 2026. For fiscal 2025 it was $806.88M, up 62.4% from the year before. The highest annual figure on record is $806.88M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$806.88M+62.4%
FY2024Dec 31, 2024$496.77M+35.0%
FY2023Dec 31, 2023$368.00M+83.8%
FY2022Dec 31, 2022$200.21M+116.6%
FY2021Dec 31, 2021$92.41M+1010.8%
FY2020Dec 31, 2020$8.32M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$735.07M+10.5%
Q1 FY2026Mar 31, 2026$750.21M+5.8%
Q4 FY2025Dec 31, 2025$806.88M+62.4%
Q3 FY2025Sep 30, 2025$630.46M+27.3%
Q2 FY2025Jun 30, 2025$665.06M+30.3%
Q1 FY2025Mar 31, 2025$709.27M+100.3%
Q4 FY2024Dec 31, 2024$496.77M+35.0%
Q3 FY2024Sep 30, 2024$495.15M+31.5%
Q2 FY2024Jun 30, 2024$510.22M+32.8%
Q1 FY2024Mar 31, 2024$354.18M+45.3%
Q4 FY2023Dec 31, 2023$368.00M+83.8%
Q3 FY2023Sep 30, 2023$376.50M+255.1%
Q2 FY2023Jun 30, 2023$384.17M+239.0%
Q1 FY2023Mar 31, 2023$243.78M+96.1%
Q4 FY2022Dec 31, 2022$200.21M+116.6%
Q3 FY2022Sep 30, 2022$106.03M-31.8%
Q2 FY2022Jun 30, 2022$113.33M-34.3%
Q1 FY2022Mar 31, 2022$124.29M-34.4%
Q4 FY2021Dec 31, 2021$92.41M+1010.8%
Q3 FY2021Sep 30, 2021$155.54M+27.1%
Q2 FY2021Jun 30, 2021$172.42M–
Q1 FY2021Mar 31, 2021$189.38M–
Q4 FY2020Dec 31, 2020$8.32M–
Q3 FY2020Sep 30, 2020$122.36M–

More Disc Medicine figures

See a number that looks wrong?